Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd clinical trials

A subsidiary of MicroPort Scientific Corporation

The registry lists 4 studies whose lead sponsor is Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 29, 2026.

Status

Recruiting: 3
Not yet recruiting: 1

Where

Germany: 2
China: 2
Switzerland: 2
Netherlands: 1
Italy: 1
Greece: 1

Registry sponsor names on this page

Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd4 studies

Something wrong with this grouping? Tell us on the MicroPort Scientific Corporation page.

Studies

Recruiting first, then most recently updated. Showing 4 of 4. All MicroPort Scientific Corporation studies →

Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm TreatmentRecruitingNCT07674173
Sponsor listed in the registry: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™RecruitingNCT07668687
Sponsor listed in the registry: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology ReconstructionNot yet recruitingNCT07139912Not applicable
Sponsor listed in the registry: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
CRATOS - Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta LesionsRecruitingNCT05874206Not applicable
Sponsor listed in the registry: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd